Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease - PubMed (original) (raw)
- PMID: 4962590
Free article
Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease
P B Schneider et al. J Lipid Res. 1967 May.
Free article
Abstract
This paper describes the purification and some of the properties of an enzyme from human spleen that catalyzes the hydrolysis of sphingomyelin with the formation of ceramide and phosphoryl choline. The enzyme, which is located in the subcellular particulate fraction that sediments between 700 and 8500 g, is readily made soluble and has been partially purified. Its pH optimum is between 4.5 and 5.0. It is unaffected by divalent cations, chelating agents, and sulfhydryl reagents, but is inhibited by phosphate. The enzyme attacks sphingomyelin and dihydrosphingomyelin, but is inactive toward sphingosine phosphoryl choline, O-acetylsphingomyelin, and lecithin. In some of its properties, the enzyme from human spleen is different from the previously studied sphingomyelinase from rat tissues. The enzyme is absent or markedly reduced in spleens from patients with classical and visceral varieties of Niemann-Pick disease, but is present in normal amounts in the late infantile type of the disease. In the present study another enzyme, this one magnesium-dependent, capable of catalyzing the cleavage of sphingomyelin has been detected in the spleens of patients with the classical form of Niemann-Pick disease. Some implications of these findings for theories of the metabolic defect in Niemann-Pick disease are discussed.
Similar articles
- Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.
Christomanou H. Christomanou H. Hoppe Seylers Z Physiol Chem. 1980 Oct;361(10):1489-502. doi: 10.1515/bchm2.1980.361.2.1489. Hoppe Seylers Z Physiol Chem. 1980. PMID: 6256275 - [Phospholipid splitting enzymes. 3].
Matsumoto M, Tamiya K, Suzuki Y, Miwa M. Matsumoto M, et al. Tanpakushitsu Kakusan Koso. 1969 Sep;14(10):906-15. Tanpakushitsu Kakusan Koso. 1969. PMID: 4311380 Review. Japanese. No abstract available. - [New views on thesaurismoses].
Prazák Z. Prazák Z. Cesk Pediatr. 1970 Jul;25(7):345-50. Cesk Pediatr. 1970. PMID: 4246729 Review. Czech. No abstract available.
Cited by
- Niemann-Pick's disease. Clinical, biochemical and ultrastructural findings in a case of the infantile form.
da Silva V, Vassella F, Bischoff A, Spycher M, Wiesmann UN, Herschkowitz N. da Silva V, et al. J Neurol. 1975 Dec 2;211(1):61-8. doi: 10.1007/BF00312464. J Neurol. 1975. PMID: 56432 - Progress in investigations of sphingolipidoses.
Adachi M, Schneck L, Volk BW. Adachi M, et al. Acta Neuropathol. 1978 Aug 7;43(1-2):1-18. doi: 10.1007/BF00684994. Acta Neuropathol. 1978. PMID: 97916 Review. No abstract available. - Properties of palmitoyl phosphatidylcholine, sphingomyelin, and dihydrosphingomyelin bilayer membranes as reported by different fluorescent reporter molecules.
Nyholm T, Nylund M, Söderholm A, Slotte JP. Nyholm T, et al. Biophys J. 2003 Feb;84(2 Pt 1):987-97. doi: 10.1016/S0006-3495(03)74915-7. Biophys J. 2003. PMID: 12547780 Free PMC article. - Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.
Prinetti A, Prioni S, Chiricozzi E, Schuchman EH, Chigorno V, Sonnino S. Prinetti A, et al. Neurochem Res. 2011 Sep;36(9):1654-68. doi: 10.1007/s11064-010-0380-3. Epub 2011 Jan 5. Neurochem Res. 2011. PMID: 21207141 Review. - Sphingolipidoses.
Yatsu FM. Yatsu FM. Calif Med. 1971 Apr;114(4):1-6. Calif Med. 1971. PMID: 5551302 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical